argipressin, beta-mercapto-beta,beta-cyclopentamethylenepropionic acid(1)-Ile(2)-Abu(4)-: an arginine vasopressin (AVP) V2 receptor antagonist
ID Source | ID |
---|---|
PubMed CID | 174700 |
MeSH ID | M0157687 |
Synonym |
---|
argipressin, beta-mercapto-beta,beta-cyclopentamethylenepropionic acid(1)-ile(2)-abu(4)- |
(2s)-n-[(2r)-1-[(2s)-2-[[(2s)-1-[[2-(2-aminobutanoylamino)-2-oxoethyl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-3-sulfanylidenepropan-2-yl]-2-[[(2s)-2-[[(2r,3r)-3-methyl-2-[[2-(1-sulfanylcyclohexyl)acetyl]amino]p |
vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-d-isoleucine-4-(l-2-aminobutanoic acid)-8-l-arginine- |
1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-ile-4-abu-argipressin |
arginine vasopressin,beta-mercapto-beta,beta-cyclopentamethylenepropionic acid(1)-ile(2)-abu(4)- |
argipressin, beta-mercapto-beta,beta-cyclopentamethylenepropionic acid(1)-isoleucyl(2)-aminobutanoic acid(4)- |
88686-52-6 |
d(ch2)5(d-ile(2),abu(4))avp |
d(ch2)5-ile(2)-abu(4)-avp |
d(ch2)5-2-ile-4-abu-argipressin |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.80) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |